Physician profile
John M Tomich
NPI 1295705994
$1,252.08
in general payments reported to CMS, 2019-2025
16 companies · $44.22 in 2025
The $44.22 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $202 · 2021: $28.67 · 2025: $44.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $193.06 | 2019-2020 | |
| Pfizer INC. | $192.48 | 2019-2020 | |
| Abbvie INC. | $176.79 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $100.34 | 2019 | |
| Lilly USA, LLC | $97.80 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $96.36 | 2019-2020 | |
| Janssen Biotech, INC. | $80.06 | 2019-2020 | |
| Amgen INC. | $63.41 | 2019-2020 | |
| Ucb, INC. | $48.49 | 2019-2020 | |
| Gilead Sciences, INC. | $44.22 | 2025 | |
| Genzyme Corporation | $43.56 | 2019-2020 | |
| Celgene Corporation | $39.29 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.15 | 2019 | |
| Dermira, INC. | $22.69 | 2019 | |
| Almirall LLC | $17.55 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $11.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tomich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.